Latest Intellectual Property News

Axtec has secured a strategic partnership with MRI Software to integrate its full product suite into widely used Australian real estate software, opening a major distribution channel across agent networks nationwide.

Li-S Energy marked key commercial and regulatory milestones in Q2 2026, including ISO 9001:2015 certification for its lithium foil line, first commercial foil sale, and US air transport approvals for lithium-sulfur cells. The company also completed a major Battery Testing Centre expansion and began deep-ocean cell testing with MSubs.

Genetic Signatures has completed a major restructure delivering $5 million in annual savings from FY2027 and secured a decade-long supply contract with Denmark’s Hvidovre Hospital, while posting $14.8 million revenue for FY2026 amid market pressures.

Ardea Resources pushes back the completion of its Kalgoorlie Nickel Project DFS to pursue optimisation opportunities, while securing strong multi-level government backing and maintaining a robust financial position.

Entropy Neurodynamics has reported breakthrough Phase 2 clinical results for its intravenous psilocin therapy in treatment-resistant Binge Eating Disorder, alongside strong Phase 2a data in Irritable Bowel Syndrome and a new US patent filing.

Ceretas Limited is raising $8 million through an IPO to fund clinical trials and development of its novel therapeutic ultrasound device targeting Alzheimer’s disease symptoms.

Pure Resources has achieved a key early milestone with Oak Ridge National Laboratory confirming the recovery of heavy rare earth elements from garnet concentrate at its Garnet Hills Project. While still at proof-of-concept stage, this validates the potential for a new source of critical minerals.

AdNeo Limited achieved a record positive operating cash flow of $451k in Q4 FY26 and secured significant customer contracts, setting the stage for disciplined growth in FY27.

WhiteHawk Limited is offering 139.3 million WHKOB Options to placement participants and its lead manager, exercisable at $0.013 and expiring in 2029. The options are issued for nil consideration, with potential proceeds of $1.81 million if fully exercised.

Entropy Neurodynamics has expanded its global intellectual property portfolio with a South African patent for psilocybin-based fibromyalgia treatment, covering broad therapeutic methods and extending protection to 2043.

Hazer Group has completed a key commercial-scale hydrogen process design package with KBR, boosting its readiness for large-scale deployment and expanding its project pipeline across multiple sectors and geographies.

Neurotech International has locked in a $3.15 million secured loan against its anticipated R&D tax incentives to fund pivotal Phase III autism trials and ongoing operations.